The given sequence checksum does not match our current record for P26718!
P26718 (NKG2D_HUMAN) Homo sapiens (Human)
NKG2-D type II integral membrane protein UniProtKBInterProSTRINGInteractive Modelling
216 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human MICA mutants in complex with natural killer cell receptor NKG2D |
Heteromer Q29983; | 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of human MICA mutants in complex with natural killer cell receptor NKG2D |
Heteromer Q29983; | 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of human MICA mutants in complex with natural killer cell receptor NKG2D |
Heteromer Q29983; | |||||
| Assess | ||||||
| Crystal structure of human MICA mutants in complex with natural killer cell receptor NKG2D |
Heteromer Q29983; | |||||
| Assess | ||||||
| Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys |
Heteromer Q29983; | 2×NAG; 4×NAG; 1×GOL; | ||||
| Assess | ||||||
| Preclinical Characterization of Pan-NKG2D Ligand-Binding NKG2D Receptor Decoys |
Heteromer Q29983; | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D |
Heteromer Q29983; | |||||
| Assess | ||||||
| Crystal structure of NKG2D in complex with ULBP6 |
Heteromer Q5VY80; | |||||
| Assess | ||||||
| Crystal structure of human MICA mutants in complex with natural killer cell receptor NKG2D |
Heteromer Q29983; | |||||
| Assess | ||||||
| Crystal structure of Cowpox virus CPXV018 (OMCP) bound to human NKG2D |
Heteromer Q8QN43; | |||||
| Assess | ||||||
| NKG2D in complex with ULBP3 |
Heteromer Q9BZM4; | 1×GSH; | ||||
| Assess | ||||||
| Crystal Structure of the free human NKG2D immunoreceptor | homo-2-mer | 2×PO4; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 4e | homo-2-mer | 1×VMW; 2×PEG; 1×GOL; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 36 | homo-2-mer | 4×PGE; 1×ZWA; 1×PG4; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 14 | homo-2-mer | 4×PGE; 1×PEG; 1×ZW7; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 4d | homo-2-mer | 1×PGE; 1×VMQ; 2×PEG; 1×PG4; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 1a | homo-2-mer | 1×VN8; 2×PGE; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 3g | homo-2-mer | 2×PEG; 1×VMH; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 4f | homo-2-mer | 2×PEG; 1×VN2; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 3e | homo-2-mer | 1×VMB; | ||||
| Assess | ||||||
| NKG2D complexed with inhibitor 4a | homo-2-mer | 6×PGE; 2×PEG; 1×VML; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1mpu.1.B | homo-2-mer | 0.77 | 99.28 | |||
| Assess | ||||||